Stock Events

Stock Events

Candel Therapeutics (CADL) Q2 2024 Earnings

14MayConfirmed

Q1 2023

Q2 2023

Q3 2023

Q2 2024

-0.34

-0.23

-0.11

0

Details

Expected EPS

N/A

Actual EPS

-0.28

Surprise EPS

-0.28

Surprise Percent

+∞%

Description

Candel Therapeutics (CADL) has reported earnings of -0.28 per share for Q2 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.